MedTrace Logo

PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

NCT04444609 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2022-05-25

No results posted yet for this study

Summary

DESIGN Longitudinal prospective observational multicentre study.

Primary objective:

Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease

Conditions

  • COVID-19
  • SARS-CoV 2
  • ARDS, Human
  • Immune System Disorder

Interventions

OTHER

Blood tests sputum, nasal lavage and brushing

Venesection, sputum nasal lavage and brushing if appropriate

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • Chelsea and Westminster NHS Foundation Trust

    collaborator OTHER

  • Imperial College Healthcare NHS Trust

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Peter Kelleher, MD PhD · Imperial College London

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04444609 on ClinicalTrials.gov